Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 202420
Company: CHARTWELL MOLECULAR

Products on ANDA 202420

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
CALCIUM ACETATE	CALCIUM ACETATE	667MG	TABLET;ORAL	Prescription	AB	No	Yes

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 202420

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
02/05/2013	ORIG-1	Approval				Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
05/01/2026	SUPPL-5	Labeling-Package Insert, Labeling-Container/Carton Labels		Label is not available on this site.

Therapeutic Equivalents for ANDA 202420

CALCIUM ACETATE

TABLET;ORAL; 667MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
CALCIUM ACETATE	CALCIUM ACETATE	667MG	TABLET;ORAL	Prescription	No	AB	202420	CHARTWELL MOLECULAR
CALCIUM ACETATE	CALCIUM ACETATE	667MG	TABLET;ORAL	Prescription	No	AB	202885	HERITAGE PHARMS INC